| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
|
N Engl J Med
|
1998
|
6.75
|
|
2
|
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.
|
J Pediatr
|
2000
|
3.53
|
|
3
|
Natural history of neonatal herpes simplex virus infections in the acyclovir era.
|
Pediatrics
|
2001
|
2.91
|
|
4
|
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
|
J Infect Dis
|
2000
|
2.90
|
|
5
|
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.
|
Pediatrics
|
2001
|
2.30
|
|
6
|
Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein.
|
J Infect Dis
|
1998
|
2.24
|
|
7
|
Influenza virus infections in infants.
|
Pediatr Infect Dis J
|
1997
|
1.75
|
|
8
|
Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults.
|
Neth J Med
|
2008
|
1.57
|
|
9
|
Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.
|
Clin Infect Dis
|
2008
|
1.55
|
|
10
|
Serum vitamin A levels in respiratory syncytial virus infection.
|
J Pediatr
|
1994
|
1.53
|
|
11
|
Twenty years of outpatient respiratory syncytial virus infection: a framework for vaccine efficacy trials.
|
Pediatrics
|
1997
|
1.51
|
|
12
|
Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children.
|
Vaccine
|
1999
|
1.37
|
|
13
|
Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
|
Philos Trans R Soc Lond B Biol Sci
|
2001
|
1.26
|
|
14
|
Neonatal meningitis due to Lactobacillus.
|
Pediatr Infect Dis
|
1983
|
1.22
|
|
15
|
Prevention of otitis media in children with live attenuated influenza vaccine given intranasally.
|
Pediatr Infect Dis J
|
2000
|
1.17
|
|
16
|
A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years.
|
Vaccine
|
2011
|
1.12
|
|
17
|
Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
|
Pediatrics
|
1997
|
1.11
|
|
18
|
Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children.
|
Pediatrics
|
1997
|
1.05
|
|
19
|
Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum.
|
Pediatr Res
|
1993
|
1.02
|
|
20
|
A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trial.
|
Vaccine
|
2012
|
0.98
|
|
21
|
Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat.
|
Pediatr Res
|
1987
|
0.93
|
|
22
|
Acquisition of cytomegalovirus infection from birth to 10 years: a longitudinal serologic study.
|
J Pediatr
|
1987
|
0.91
|
|
23
|
Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children.
|
Vaccine
|
1993
|
0.83
|
|
24
|
Enzyme-linked immunosorbent assay to assess respiratory syncytial virus concentration and correlate results with inflammatory mediators in tracheal secretions.
|
Pediatr Infect Dis J
|
2000
|
0.83
|
|
25
|
Topical immunoprophylaxis of respiratory syncytial virus (RSV)-challenged mice with RSV-specific immune globulin.
|
J Infect Dis
|
1995
|
0.81
|
|
26
|
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants.
|
Vaccine
|
2011
|
0.79
|
|
27
|
Single-dose pharmacokinetics of imipenem-cilastatin in neonates.
|
Antimicrob Agents Chemother
|
1985
|
0.78
|
|
28
|
Predicting pneumococcal community-acquired pneumonia in the emergency department: evaluation of clinical parameters.
|
Clin Microbiol Infect
|
2014
|
0.77
|
|
29
|
Evaluation of an intravenous immunoglobulin preparation for the prevention of viral infection among hospitalized low birth weight infants.
|
Pediatr Infect Dis J
|
1990
|
0.76
|
|
30
|
Safety and pharmacokinetics of vitamin A therapy for infants with respiratory syncytial virus infections.
|
Antimicrob Agents Chemother
|
1995
|
0.76
|
|
31
|
Vitamin A therapy for respiratory syncytial virus infection.
|
Pediatr Infect Dis J
|
1997
|
0.75
|